|
ANKRD56 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.36983782492462E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88410398394012E-11 |
| Normal-vs-Stage2 |
3.292000E-02 |
| Normal-vs-Stage3 |
1.26479999806861E-08 |
| Normal-vs-Stage4 |
1.02479999997129E-06 |
| Stage1-vs-Stage2 |
1.293860E-02 |
| Stage1-vs-Stage3 |
4.823200E-01 |
| Stage1-vs-Stage4 |
7.448800E-01 |
| Stage2-vs-Stage3 |
7.855000E-03 |
| Stage2-vs-Stage4 |
2.222400E-02 |
| Stage3-vs-Stage4 |
7.878200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63757896132211E-12 |
| Normal-vs-AfricanAmerican |
6.152600E-04 |
| Normal-vs-Asian |
5.013500E-04 |
| Caucasian-vs-AfricanAmerican |
4.496600E-01 |
| Caucasian-vs-Asian |
2.036000E-01 |
| AfricanAmerican-vs-Asian |
1.315180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85149999998302E-07 |
| Normal-vs-Female |
2.31414887252868E-12 |
| Male-vs-Female |
3.666600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.90570004221513E-10 |
| Normal-vs-Age(41-60Yrs) |
3.09020031785678E-10 |
| Normal-vs-Age(61-80Yrs) |
2.45119999999766E-05 |
| Normal-vs-Age(81-100Yrs) |
2.761200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.984800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.275390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.548400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.908000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.245800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.748600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.994400E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
7.576000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
8.59790000307115E-08 |
| Tall-VS-Other |
8.273600E-01 |
| Tall-VS-Normal |
2.87790000053079E-07 |
| Follicular-VS-Other |
3.934100E-02 |
| Follicular-VS-Normal |
5.125400E-01 |
| Other-VS-Normal |
4.980000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.02389999987207E-07 |
| Normal-vs-N1 |
3.207000E-04 |
| N0-vs-N1 |
3.528000E-01 |
|
|
